Contract Manufacturing Industry News

  1. SCM Unveils Formulation Service
    UK-based SCM Pharma is set to officially launch its own formulation development capability after acquiring new facilities as part of a collaborative deal with the University of Sunderland.
  2. Catalent Announces Partnership With Toyobo Biologics, Inc. To Co-Promote GPEx Technology In Japanese Market
    Catalent Pharma Solutions, a leading provider of drug and biologic development services, delivery technologies and supply solutions, and Toyobo Biologics, Inc. (TBI) jointly announced recently that they have entered into a partnership agreement to co-promote Catalent’s proprietary GPEx technology in the Japanese market.
  3. PPD Appoints Raymond Hill As Chief Executive Officer And Member Of The Board Of Directors
    PPD, Inc. recently announced that its board of directors has named Raymond H. Hill as PPD's new chief executive officer and elected him to the board of directors, both effective September 16.
  4. Lonza Extends Tender Offer For All Outstanding Shares Of Arch Chemicals Common Stock To 30 September 2011
    Lonza Group Ltd, one of the world’s leading suppliers to the life science industries, announced recently that LG Acquisition Corp., an indirect wholly owned subsidiary of Lonza, has extended the expiration date for its previously announced tender offer for 100 percent of the outstanding shares of common stock of Arch Chemicals, Inc..
  5. Single-Use BioFlex Tubing Assemblies Featured In New Brochure
    Meissner has just released a new brochure featuring its BioFlex tubing assemblies. The single-use tubing assemblies are designed for secure fluid transfer in critical biopharmaceutical processing applications.
  6. FUJIFILM And Dr. Reddy’s To Establish An Exclusive Joint Venture For Developing, Manufacturing And Promoting Generic Drugs In Japan
    FUJIFILM Corporation (Head office: Tokyo, Japan) President and CEO, Shigetaka Komori (“Fujifilm” hereinafter) and Dr. Reddy's Laboratories Ltd. (Head office: Hyderabad, India) Vice-Chairman and CEO, G V Prasad ("Dr. Reddy’s" hereinafter) recently signed a Memorandum of Understanding (the “MoU” hereinafter) to enter into an exclusive partnership in the generic drugs business for the Japanese market and to establish a joint venture in Japan.
  7. JHP Pharmaceuticals To Produce Clinical Batches Of Innovative Cardiac Drug

    JHP Pharmaceuticals, a leading provider of contract manufacturing services for sterile injectable products has entered into an agreement with an undisclosed biotech company to produce clinical trial batches of an innovative drug used in the treatment of heart failure.

  8. Lonza Signs Manufacturing Deal With IMMUNE Pharmaceuticals For Bertilimumab (iCo-008)
    Lonza announced today an exclusive contract for the production of IMMUNE Pharmaceutical’s human immunoglobulin monoclonal antibody, Bertilimumab, under investigation for the potential treatment of several inflammatory disorders.
  9. Dr. Reddy's Announces The Launch Of Amlodipine Besylate And Benazepril Hydrochloride Capsules
    Dr. Reddy’s Laboratories (NYSE: RDY) announced today that it has launched Amlodipine Besylate and Benazepril Hydrochloride capsules (5 mg/40 mg and 10 mg/40 mg), a bioequivalent generic version of LOTREL®* capsules in the US market on July 5, 2011, following the approval by the United States Food & Drug Administration (USFDA) of Dr. Reddy’s ANDA for Amlodipine Besylate and Benazepril Hydrochloride capsules.
  10. JHP Pharmaceuticals Enters Agreement To Produce Life-Saving Drug

    JHP Pharmaceuticals, a leading provider of contract manufacturing services for sterile injectable products has entered into an agreement with an undisclosed pharmaceutical company. The agreement is for the product transfer and registration batch production of a life-saving drug.